Novel approach for comparing the abilities of quinolones to restrict the emergence of resistant mutants during quinolone exposure

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 1, 2010, Pages 149-156

  Malik, Muhammad ^a   Hoatam, Gerard ^a   Chavda, Kalyan ^a   Kerns, Robert J ^b   Drlica, Karl ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 METHOXY QUINAZOLINE 2,4 DIONE; C ETHYL PIPERAZINE; DNA TOPOISOMERASE (ATP HYDROLYSING) A; N ETHYL PIPERAZINE; NALIDIXIC ACID; PIPERAZINE; PROTEIN INHIBITOR; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; GENE MUTATION; GENE STRUCTURE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; ANTIMUTAGENIC AGENTS; BACTERIA; BASE SEQUENCE; CULTURE MEDIA; DNA GYRASE; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FLUOROQUINOLONES; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; NALIDIXIC ACID;

EID: 73849106268     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01035-09     Document Type: Article

References (24)

1. Chen, C.-R., M. Malik, M. Snyder, and K. Drlica. 1996. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage. J. Mol. Biol. 258:627-637.
2. Cirz, R., J. Chin, D. Andes, V. Crecy-Lagard, W. Craig, and F. E. Romesberg. 2005. Inhibition of mutation and combating the evolution of antibiotic resistance. PLoS Biol. 3:1024-1033.
3. Cirz, R., and F. Romesberg. 2006. Induction and inhibition of ciprofloxacin resistance-conferring mutations in hypermutator bacteria. Antimicrob. Agents Chemother. 50:220-225.
4. Cui, J., Y. Liu, R. Wang, W. Tong, K. Drlica, and X. Zhao. 2006. The mutant selection window demonstrated in rabbits infected with Staphylococcus aureus. J. Infect. Dis. 194:1601-1608.
5. Dong, Y., X. Zhao, J. Domagala, and K. Drlica. 1999. Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Staphylococcus aureus. Antimicrob. Agents Chemother. 43:1756-1758.
6. Drlica, K., and X. Zhao. 2007. Mutant selection window hypothesis updated. Clin. Infect. Dis. 44:681-688.
7. Duncan, B. K. 1985. Isolation of insertion, deletion, and nonsense mutations of the uracil-DNA glycosylase (ung) gene of Escherichia coli K-12. J. Bacteriol. 164:689-695.
8. Engle, E. C., S. H. Manes, and K. Drlica. 1982. Differential effects of antibiotics inhibiting gyrase. J. Bacteriol. 149:92-98.
9. Friedman, S. M., T. Lu, and K. Drlica. 2001. A mutation in the DNA gyrase A gene of Escherichia coli that expands the quinolone-resistance- determining region. Antimicrob. Agents Chemother. 45:2378-2380.
10. German, N., M. Malik, J. Rosen, K. Drlica, and R. Kerns. 2008. Use of gyrase resistance mutants to guide selection of 8-methoxy-quinazoline-2,4- diones. Antimicrob. Agents Chemother. 52:3915-3921.
11. Hane, M. W., and T. H. Wood. 1969. Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies. J. Bacteriol. 99: 238-241.
12. Lipsitch, M., and B. Levin. 1997. The population dynamics of antimicrobial chemotherapy. Antimicrob. Agents Chemother. 41:363-373.
13. Liu, Y., J. Cui, R. Wang, X. Wang, K. Drlica, and X. Zhao. 2005. Selection of rifampicin-resistant Staphylococcus aureus during tuberculosis therapy: concurrent bacterial eradication and acquisition of resistance. J. Antimicrob. Chemother. 56:1172-1175.
14. Lu, T., X. Zhao, and K. Drlica. 1999. Gatifloxacin activity against quinolone-resistant gyrase: allele-specific enhancement of bacteriostatic and bactericidal activity by the C-8-methoxy group. Antimicrob. Agents Chemother. 43:2969-2974.
15. Malik, M., X. Zhao, and K. Drlica. 2006. Lethal fragmentation of bacterial chromosomes mediated by DNA gyrase and quinolones. Mol. Microbiol. 61:810-825.
16. Miller, J. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
17. Piddock, L. J., R. N. Walters, and J. M. Diver. 1990. Correlation of quinolone MIC and inhibition of DNA, RNA, and protein synthesis and induction of the SOS response in Escherichia coli. Antimicrob. Agents Chemother. 34:2331-2336.
18. Robbins-Manke, J., Z. Zdraveski, M. Marinus, and J. Essigmann. 2005. Analysis of global gene expression and double-strand-break formation in DNA adenine methyltransferase- and mismatch repair-deficient Escherichia coli. J. Bacteriol. 187:7027-7037.
19. Robicsek, A., G. Jacoby, and D. Hooper. 2006. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect. Dis. 6:629-640.
20. Sieradzki, K., R. Roberts, S. Haber, and A. Tomasz. 1999. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N. Engl. J. Med. 340:517-523.
21. Sternglanz, R., S. DiNardo, K. A. Voelkel, Y. Nishimura, Y. Hirota, A. K. Becherer, L. Zumstein, and J. C. Wang. 1981. Mutations in the gene coding for Escherichia coli DNA topoisomerase I affecting transcription and transposition. Proc. Natl. Acad. Sci. U. S. A. 78:2747-2751.
22. Wall, J. D., and P. D. Harriman. 1974. Phage P1 mutants with altered transducing abilities for Escherichia coli. Virology 59:532-544.
23. Zhao, X., C. Xu, J. Domagala, and K. Drlica. 1997. DNA topoisomerase targets of the fluoroquinolones: a strategy for avoiding bacterial resistance. Proc. Natl. Acad. Sci. U. S. A. 94:13991-13996.
24. Zhou, J., Y. Dong, X. Zhao, S. Lee, A. Amin, S. Ramaswamy, J. Domagala, J. M. Musser, and K. Drlica. 2000. Selection of antibiotic resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations. J. Infect. Dis. 182:517-525.